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RetuRning to the Question: What Does it Mean 
to use eviDence in PolicyMaking?
As Chap. 1 of this volume noted, the growth in interest in the use of evi-
dence in policymaking has been remarkable in recent years. Nowhere has 
this been truer than in the area of health policy, given the close affiliation 
and historical associations with the evidence based medicine movement. 
There has been a proliferation of formal structures, bodies, processes and 
mechanisms within government and policy making designed to facilitate 
the use of evidence in decision making. Examples include new govern-
ment agencies mandated with evidence synthesis, the establishment of 
health technology appraisal bodies, or the creation of standalone bodies at 
arm’s length or independent from government, providing syntheses for 
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public policy information (such as the UK’s ‘what works centres’). 
Reflecting these developments, there has been a commensurate expansion 
in focus on the idea and practice of evidence use in policymaking amongst 
both scholars and practitioners. This is evident in the emergence, and 
increasing profile, of journals focussed specifically on evidence utilisation, 
such as Evidence & Policy or Implementation Science, and international 
events such as the Global Evidence Summit or the What Works Global 
Summit which are now held on a regular basis. The desire to engage with 
questions surrounding evidence use appears greater than ever.
Despite these important developments, the field of work looking at 
evidence use in policymaking appears to still be in its infancy, with scholars 
struggling to make sense of evidence use in real world settings. Policy 
scholars studying efforts made to achieve ‘uptake’ of research findings are 
often struck by the use of the language of ‘evidence-based policy’ in both 
academic and professional circles with little, if any, explicit definition of 
what counts as ‘evidence’ and what it means to have that evidence ‘taken 
up’ in policy decisions. At times, it seems easier to identify a policy com-
munity advocating for ‘evidence-based policymaking’, than to find clarity 
on what the term actually means. As discussed elsewhere (Parkhurst 2017), 
many champions of ‘evidence based policy making’ express explicit con-
cern with problematic ways that evidence is used. This includes criticisms 
that policy makers ignore relevant evidence in decision making, or engage 
in ‘cherry-picking’ or manipulation of evidence for strategic ends. Yet the 
identification of unscientific practices and problems of bias in some politi-
cal processes does not produce conceptual clarity about what real world 
practices of evidence use in policy making look like and, from a normative 
perspective, what they should look like.
Improving conceptual clarity requires a more nuanced understanding 
of the process of evidence production, the epistemological status of 
research outputs (i.e. the types of knowledge claims which are substanti-
ated by a given study or piece of evidence) and the process of evidence use. 
Reflecting this, many policy scholars interested in questions of evidence 
use have shifted from a discourse of ‘evidence based’ to ‘evidence informed’ 
policymaking reflecting the realisation that evidence is one influence on 
policy amongst many (including ideological orientation of governments 
and societies and the political priorities and consent over the direction of 
policy by the populations affected by decisions). Moreover, the shift in 
language reflects the realisation that, while evidence can guide decisions, 
or inform us about the likely consequences of policy choices, it cannot 
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guide what policy objectives governments ought to choose. This is particu-
larly the case where governments face often mutually exclusive choices 
between competing policy agendas promoted by multiple policy advocates 
in the contexts of finite resources.
Chapter 1 also noted that there have been many attempts to identify the 
multiple ways research or evidence might influence policy, with works by 
those such as Carol Weiss (1979, 1982, 1991), or Sandra Nutley, Huw 
Davies and colleagues (see Davies et al. 2000; Nutley et al. 2007, 2013) 
mapping out many of the most common ways that pieces of research or 
evidence appear to influence decisions. There is also no shortage of system-
atic reviews that have been conducted attempting to draw together empiri-
cal work on the subject, identifying barriers and facilitators to evidence use 
of one kind or another (c.f. Oliver et  al. 2014; Mitton et  al. 2007; 
Contandriopoulos et al. 2010; McCormack et al. 2013). However, there is 
still a gap in the literature relating to understanding the politics of evidence 
use, which warrants specific attention to be given to policy processes, the 
actors involved, the forms of contestation associated with policymaking, and 
the institutions that shape these processes and, by extension, evidence use.
A public policy perspective can integrate and move beyond initial typol-
ogies to understand the ways in which contextual factors shape evidence 
use in different policy environments. In particular, forms of political con-
testation around policy problems and their putative solutions, and institu-
tional structures – including political systems in which policy responses are 
formulated and decisions are taken – shape the use of evidence in health 
policymaking. In the following sections, we reflect on how the case studies 
presented in the current volume provide insights into these three areas and 
into understanding the processes of evidence informed policy making 
more generally. We conclude with a broader discussion about the possible 
trajectories of future research agendas on evidence use in policymaking.
instRuMental uses of eviDence
As has been identified previously (Smith 2013a; Russell et  al. 2008; 
Cairney 2016), the public health community’s language and thinking 
about evidence use often reflects Weiss’ mostly instrumental meanings of 
research utilisation (i.e. her ‘knowledge-driven’ or ‘problem-solving’ 
models (Weiss 1979)). Yet politics and political systems tend to result in 
policy processes that rarely resemble this rational-linear, instrumental 
model (c.f. Weiss 1979, 1991; Russell et al. 2008; Hammersley 2013).
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Our case studies illustrate that there can be particular institutional 
arrangements in place which make instrumental uses of evidence more 
likely; arrangements that are typically created for exactly this purpose. The 
concept of evidence advisory systems, explored in Chap. 8 in particular, 
points to ways that formalised infrastructures might be deployed to ensure 
that both a supply of policy relevant evidence is available (e.g. research 
being undertaken, data collected, or bodies of evidence summarised), and 
that there are mechanisms through which decision makers can use policy- 
relevant evidence to inform decision making. We saw such systems have 
important effects in high income countries, with the Federal Joint 
Committee (GBA) in Germany and Public Health England being specifi-
cally mandated to review the evidence on policies within their remit.
Yet we also saw structural arrangements in lower and middle income 
settings playing important roles in driving instrumental uses of evidence. 
In Colombia (see Chap. 5), the implementation of organisations such as 
IETS (modelled on the example of the English National Institute for 
Health and Care Excellence (NICE), and tasked with providing health 
technology assessments similar to NICE) demonstrates the wider applica-
bility of this model and the potential for trans-national knowledge transfer 
of evidence advisory systems, often via key individuals promoting a par-
ticular approach. In Ghana (Chap. 4), we further saw how the established 
national systems of data collection in healthcare fed into regular annual 
meetings that used such data to inform the evaluations of the health sector 
and plan for the future. Yet the Ghanaian case also illustrates that these 
systems do not remove political considerations or contestation from the 
processes of evidence use. Indeed, that chapter shows that they can rou-
tinise structures with decidedly political implications; with that chapter 
exploring how donor influence within this system could be seen to chal-
lenge local accountability processes. In a similar vein, contestation of evi-
dence in case studies from Germany and England demonstrate that 
structures built to improve or rationalise evidence use cannot entirely pre-
vent research evidence becoming embroiled in political debate and/or 
being used strategically to strengthen one side of a debate. Ultimately, we 
would argue that instrumental use relies on people actively prioritising this 
type of evidence use, sharing a belief that drawing on findings from 
research improves the quality of the outcome of decisions. In this sense, 
institutional structures to support the use of research in policy can work to 
embed this belief and reflect a willingness to enhance, and invest in, an 
instrumental role for research in supporting policy decisions.
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Political contestation anD stRategic 
uses of eviDence
The existence of political contestation around the identification of policy 
problems and decisions on their proposed solutions, even within for-
malised advisory systems, underlines the fundamentally political nature of 
the policy process and the impossibility of stepping outside of politics even 
in the context of highly technical forms of decision making. Decisions 
about issues such as the prioritisation of different policy problems in the 
context of limited resources, or the way to address complex, multi- 
dimensional health issues which derive from multiple causal factors includ-
ing those which are hard to define, isolate, and measure (e.g. the social 
determinants of health), will draw on multiple bodies of evidence – often 
in different forms and adhering to different epistemological norms. 
Unavoidably, the decision making process confronts different values, 
norms and political ideologies, in addition to whatever evidence has been 
chosen in support of the decision. An example of this is illustrated in the 
case study in Ethiopia (Chap. 3), whereby the multi-sectoral planning 
required to address nutrition in that country meant that multiple interests 
were relevant to a decision, and there were differing views on which evi-
dence was therefore relevant or how to use it to inform decisions.
Yet we have also examined cases illustrating active disagreement 
between policy stakeholders about policy goals. This contestation could 
appear visibly, or it could be less explicit. In our aid-recipient nations, for 
instance, often the conflicts between the aims of international funding 
bodies and the agendas of national governments were not necessarily pub-
licly debated. Interviews provided insights into how donor funding for 
particular research topics, or support for the construction of particular 
pieces of research (such as programmatic evaluations), could shape the 
evidence base to set policy priorities. Similarly, the political dynamics 
through which evidence of certain topics was brought to political decision 
processes was seen in some places as a mechanism for donor influence; as 
was the influence that could result when donors shaped the processes 
through which evidence and data are brought to bear on policy decisions 
(see discussion in Chap. 10; also Khan et al. 2017).
We found overt and explicit contestation more visible in our middle 
and higher income settings (although the extent to which conflict plays 
out ‘behind the scene’ was not investigated per se). In Colombia (Chap. 
5), for instance, debates around national health system reform  demonstrated 
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the importance of different ideas about the relationship between the indi-
vidual and the state and the role of the state and private enterprises in 
funding and providing healthcare in the incremental process of reforming 
the country’s health system. Whilst evidence was called upon by all sides 
to support their positions, and was cited in draft legislation in support of 
proposals, it was unable to resolve conflicts between policy actors with 
deeply entrenched ideological positions.
In England (Chap. 7), we also saw how tobacco control debates around 
new nicotine delivery systems (e-cigarettes) have polarised the public 
health community and the strategic use of evidence to support the promo-
tion of very different framing of the policy problem facing government 
and the regulatory approach it should take in addressing this. Evidence is 
cited by policy actors and researchers on both sides of the debate. For 
example, those who see the harm reduction potential of e-cigarettes point 
to studies showing reduced levels of toxicity in e-cigarette vapour versus 
tobacco smoke, whilst those taking a tobacco control perspective high-
light the lack of epidemiological studies on their long term health effects. 
At this stage of the debate, with the need for significant additional research 
needed to remove uncertainty about the long-term health effects of 
e- cigarettes, recourse to evidence is unable to resolve conflicts between 
actors who view the issue in fundamentally different terms and from dif-
ferent professional perspectives.
The competitive nature of many policy environments can be seen to 
drive Weiss’ (1979) idea of ‘strategic’ uses of evidence. In such cases, evi-
dence is seen to be used as ‘ammunition’ to achieve pre-defined positions 
or policy goals – fundamentally to ‘win’ in the competitive process. Using 
evidence strategically may risk violating established principles of good sci-
entific practice, however. It is also not compatible with notions of ‘instru-
mental’ use, although this distinction can be difficult to uphold and might 
well be part of the contestation. For example, in England, the public 
health community for many years collaborated effectively to influence 
government policy on tobacco control, strategically utilising scientific evi-
dence to support their position. This was widely seen to be a legitimate use 
of evidence. Yet the tobacco industry also routinely engaged in strategic 
uses of evidence to support arguments in opposition to tobacco control 
measures, typically in ways judged to be biased by researchers and tobacco 
control advocates (c.f. Bero 2005; Lee et al. 2004; Ulucanlar et al. 2014).
Even rules-based health governance systems such as Germany’s are 
open to strategic evidence use under conditions of contestation. The case 
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study on minimum volume regulation (Chap. 6) demonstrated that while 
the Federal Joint Committee, the body mandated with setting minimum 
volumes, is required by law to appreciate the evidence in support of mini-
mum volumes, its constituting member organisations were pitted against 
each other, with the German Hospital Association being strongly opposed 
to such regulation and marshalling its own evidence in support of its posi-
tion. Evidence in this example was therefore used both instrumentally and 
strategically.
In our case studies, we found no indication that parliaments (explored 
in Chap. 9) were particularly prone to use evidence to inform decision (i.e. 
law) making. While this subject requires substantial additional research, 
this observation seems to suggest that in settings in which contestation is 
acted out openly and purposefully, the case for using evidence in an ‘objec-
tive’ or systematic way is harder to make. While there are structures in 
place in some countries to provide scientific advice to parliamentarians and 
committees, the emphasis of parliamentary process is on creating majori-
ties and these majorities are typically formed within the context of party 
politics (although these can play out very differently in different parlia-
mentary cultures as we have seen cross our case studies). There is a debate 
to be had about the extent to which parliaments should be better informed 
by evidence. It is certainly desirable for politicians to be literate in research 
use and for political parties to have their proposals questioned by recourse 
to evidence. Yet expecting parliament to operate in an ‘evidence based’ 
fashion seems to suggest an expectation that it is possible to reduce con-
testation in (i.e. depoliticise) political debate which is a contradiction in 
terms. In fact, this is more likely to happen in political systems that inten-
tionally stifle or suppress contestation than in those with established dem-
ocratic traditions.
the constRuction of issues anD iMPact  
on eviDence use
While there may be both subtle and overt forms of contestation around 
evidence-informed policy debates, the case studies contained in this vol-
ume also point to a larger overarching theme important in shaping the use 
of evidence in health policy making. In particular, a number of cases 
explored the fundamental importance of issue construction and issue 
framing within local contexts in determining when and how evidence is 
used in the policy process.
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It might be expected that certain features of health problems make 
issues more or less conducive to particular types of evidence use. Such 
thinking is evident in the health policy literature, with the concept of ‘issue 
characteristics’ used by some to help explain global health policy agenda 
setting or the success of global health networks (Shiffman 2007; Shiffman 
et  al. 2015). The importance of issue characteristics has also been pro-
posed in other policy areas, for example, to understand what is considered 
rational policymaking in areas like global warming (Oshitani 2013), or to 
explain different bargaining strategies adopted within the EU by member 
states (McKibben 2010).
Within the health sector, scholars have argued that certain characteris-
tics of policy issues might influence the ways in which evidence is used in 
decision making. For example, there is general recognition of cases where 
issues directly impact on private sector financial interests, which has led to 
strategic uses of evidence by corporate actors. Examples of this have been 
widely documented for the tobacco and alcohol industry for instance 
(Marmot 2004; Smith 2013b; Tong and Glantz 2007; McCambridge 
et al. 2014). We also see cases where policies are contested in terms of 
moral arguments about the appropriateness of certain behaviours, includ-
ing sexual activity and drug use and the appropriate forms of treatment 
and the extent of resources which should be directed to tackling these 
conditions. A clear example of this surrounds arguments in favour of and 
against harm reduction approaches to injecting drug users (c.f Keane 
2003; Rhodes et al. 2010; Buchanan et al. 2003), or debates about sexual 
health (c.f. Epstein 2006; Lyons 1999; Wald et al. 2001).
However, the concept of ‘issue characteristics’ deployed in much of the 
health policy literature is problematic, as it can assume an overly materialist 
and objectivist conception of the nature of social problems and underplays 
the extent to which policy problems are a result of inter-discursive processes 
of problem construction by policy actors. Moreover, it is possible that there 
will be multiple (sometime starkly conflicting) accounts of the ‘same’ policy 
issue within the same policy space. Similarly, we can find examples where 
seemingly technical issues, for which one might not expect contestation to 
arise around evidence use, could become problematized in unique ways, 
resulting in debates over evidence that might not be expected based on the 
nature of the policy decision (c.f. D’Souza and Parkhurst 2018).
Rather than health issues having inherent characteristics, it is, therefore, 
more appropriate to explore how different health issues are framed or 
constructed in particular ways in different settings, and to seek to understand 
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the consequences of this for evidence use. In some of our lower- income 
fieldwork countries we asked interviewees about whether particular issues 
were highly contested, including asking about sexual health or HIV spe-
cifically. However, we did not find any respondents identifying any strong 
contestation over these in relation to their (current) work. In a similar 
vein, our interviews in Ghana identified little contestation or challenge 
around evidence use and policy formulation for tobacco control in that 
country – potentially explained by the fact that the country is not a tobacco 
producer and has relatively low smoking rates. This serves as a reminder 
that just because an issue may be deeply polarised and highly contested in 
one setting, it does not mean that the issue is inherently polarising. Nor 
does it meant that evidence around the issue will be necessarily used stra-
tegically, as has been seen with both HIV and tobacco control elsewhere 
(c.f. Parkhurst 2013; Parkhurst et al. 2015; Smith 2013b; and in Chap. 7 
in this volume).
In Cambodia (Chap. 2), policy debates around HIV/AIDS was not 
found to be characterised by strong contestation along moral lines (accord-
ing to our interviewees working primarily in national public health roles). 
Rather, it was presented as an example where evidence was used well in the 
country by respondents. In this case, ‘good evidence use’ was seen to be 
reflected in how international donor communities reviewed and relied on 
epidemiological studies to guide the choice of interventions for HIV/AIDS 
locally – a use of evidence that more reflects Weiss’ instrumental modes.
Chapter 2 also illustrates just how fluid or dynamic the understanding of 
the concept of a ‘good use’ of evidence can be, and how this itself might be 
a construct of the specific context and policy needs. A second example 
mentioned by interviewees as exemplifying a good use of evidence was 
around a national programme providing financial incentives for health 
workers to encourage pregnant women to deliver in health facilities. When 
pressed further to explain why this was an exemplar, interviewees explained 
that there was ‘evidence’ of a problem of high maternal mortality, and a 
need to achieve progress towards the millennium development goal of 
reducing maternal mortality, and this intervention was clearly well targeted 
to achieve those goals. This conceptualisation of good evidence use for 
policy, however, is quite different from most conceptualisations in the 
global public health community. Instead, this judgement appears to have 
arisen from a broader idea that evidence can identify problems, and a pro-
active policy response to those problems (regardless of the efficacy of the 
intervention) would thus provide a good example of evidence use.
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Ultimately, our cases, and the broader literature on which they build, 
point to the ways in which evidence use in policymaking reflect the inter-
action between processes of issue framing and contestation. Thus, ideas 
about the appropriate or ‘good’ use of evidence use are not fixed or uni-
versal but vary between policy contexts and even between issues within the 
same context depending on the way in which a policy problem and their 
solutions are constructed and the institutional context in which policy 
decisions are taken.
aDDing institutional analysis
From the policy perspective adopted in this volume, political institutions 
are of central importance to help understand the use of research evidence 
in health policymaking. Chapter 1 noted that there was a sizable gap in the 
literature of work exploring the institutional arrangements that work to 
shape which evidence is used, when, by whom, and to what ends. The 
chapters in this volume draw out a number of ways that institutions play 
key roles in shaping policy processes and by extension evidence use for 
health policymaking, providing a second key area of insight in addition to 
the nature of political contestation and issue construction.
One way institutions can influence evidence utilisation is by shaping 
which policy actors are involved in the policy process, or have access to 
those directly involved, and thus whose positions are considered. This was 
clearly illustrated in the analysis of Ghana (Chap. 4), where the formal 
processes of data analysis for policy review routinised the important roles 
that international donors had in the policy process. The comparative eval-
uation of evidence advisory systems in Chap. 8 similarly illustrated cases 
where some key stakeholders might be structured into policy-relevant 
positions due to institutional arrangements. In Germany’s corporatist 
health governance system, non-state actors such as hospital or sickness 
fund associations, influence policy directly as they are legally mandated to 
be part of the top decision-making committee, while other actors have a 
minor or no role in decision making (e.g. patient organisations are con-
sulted but do not have voting rights). Finally, the comparative analysis 
presented in Chap. 9 explored how formal authority over particular health 
decisions could lie with legislatures or judiciaries in countries, with impor-
tant implications for how evidence would be considered and used as a 
result. Questions arise as to how these bodies are equipped when dealing 
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with scientific evidence and whether there are limits to what can be 
achieved in terms of faithfulness to the scientific production of such evi-
dence (Jasanoff and Nelkin 1981).
However, there can be less formal norms and practices that are institu-
tionalised within key policymaking structures which could have implica-
tions for evidence use. March and Olsen’s (2006) concept of institutional 
‘logics of appropriateness’ can be seen to capture the ways that expectations 
about evidence, and understandings around how policy-relevant evidence 
can be embedded within different decision making bodies. Chapter 3 drew 
explicitly on this concept in Ethiopia to explore how the expectations and 
norms of evidence use could differ between government sectors, with 
potential implications for how evidence may or may not be used to inform 
multi-sectoral planning on nutrition. Similarly, the judicialisation of certain 
health policy decisions in Colombia (Chap. 5), particularly in relation to 
the provision of medicines and treatments led to different conceptualisa-
tions around what evidence is relevant to inform decisions than was the 
case in policy deliberations within the legislative-executive nexus (for a 
more detailed account, see Hawkins and Alvarez Rosete 2017). In Germany, 
courts grappled with the concept of ‘hierarchies of evidence’ demanding 
randomised controlled trials to provide the evidence in support of certain 
minimum volumes, irrespective of the fact that these studies do not exist 
and are not feasible to be conducted, especially not in the context of 
German hospital care. In addition, judicial decisions are typically based on 
the correct application of legally and constitutionally enshrined rights to 
specific individuals, but courts may be ill equipped to take account of the 
wider social and economic consequences of the decision, such as the 
implications of the ruling in question for resource allocation elsewhere in 
the system or the overall financial sustainability of the health system 
(although there are significant differences in legal practice in this respect 
between countries).
Institutions thus influence the use of evidence in policymaking for 
health in multiple ways. First, institutional arrangements can provide 
direction to both thinking and action involving evidence use. For exam-
ple, the logics of appropriateness embedded within government institu-
tions around evidence may make it more likely for civil servants to engage 
with research and evidence in some policy fields (health) than in others 
(justice) and in some countries (UK) than in others. Yet as discussed 
above, power and contestation remain highly relevant in the framing and 
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problematisation of health issues, with important implications for evidence 
use. Second, institutions play a role in providing the venues in which such 
contestation and debate can take place. Institutional arrangements thus 
provide opportunities in terms of policy spaces where actors with access to 
these spaces can engage in issue construction and contestation processes. 
These processes may see stakeholders actively utilising pieces of evidence 
to problematize issues, but the resultant constructions will also establish 
frames of understanding that will have further implications for how differ-
ent pieces of evidence are judged relevant to policy debates. For example, 
contestation of e-cigarette policy that in England largely played out within 
the scientific community and  government public health bodies, in 
Germany led to legal challenge, so that the court system became the prin-
cipal arena for contestation. This consequently limited the policy options 
for e-cigarette regulation in Germany, with little acknowledgement of the 
limited knowledge and research available at the time on the effects of 
e-cigarettes.
Third, while providing arenas for contestation and issue construction, 
institutional arrangements also serve to establish limits, with only certain 
actors having access to these spaces, or with the strength of norms and 
rules providing boundaries on how policy actors might shape and frame 
evidence to inform policy decisions. For example, Chap. 9 explored the 
roles of the judiciary and legislature and how these can play important 
roles in health policymaking and thus evidence use. As would be expected, 
those institutional arrangements regularly see contestation and debate, 
but they also shape and limit which types of actors and which types of 
arguments are made in relation to evidence use.
RefRaMing eviDence BaseD Policy Making 
foR the PuBlic health sectoR
Health sector actors regularly speak of the need to use evidence to achieve 
their goal of improving individual and population health. However, as has 
been discussed, what evidence use actually means can take a variety of 
forms and means different things in different contexts. Thus there is a 
need for more explicit reflection on what sorts of evidence use might best 
serve health sector goals, as well as recognition of the ways that public 
health actors’ conceptualisations of evidence use may be insufficient given 
the realities of the policy process.
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The health sciences are in many ways deterministic, in as much as clinical 
medicine and epidemiology build on investigations of the natural world and 
physical bodies, and often seek to identify direct cause-effect relationships 
affecting human morbidity and mortality. Many key actors in the health 
sector have thus been trained in disciplines that look to control for context 
when considering interventions in order to be able to say ‘what works’ to 
reduce illness and improve health. From this perspective, it may seem logi-
cal or self-evident that strategies to increase evidence use will translate into 
more effective policies and interventions. Yet this fails to appreciate the 
existence of multiple relevant bodies of evidence and multiple ways in which 
that evidence may feed into complex policy decisions, in which health policy 
debates cannot be separated from the wider political context.
The fact that evidence use has many meanings is not a new insight, of 
course. However, this volume moves beyond a mapping of possible uses, 
to explore how different forms of evidence and evidence use arise and play 
out in relation to different issues and in different policy contexts. The case 
studies presented here illustrate how evidence use is shaped by various 
aspects of the policy, the institutional context in which policy decision are 
taken and the active agency of policy actors which will seek to frame per-
ceptions of policy problems and their solutions in different ways, which 
impact in turn on the ways in which different bodies of evidence feed into 
the policy decisions.
A key message for health policy actors is to take on board the insights 
from policy analysis presented in this volume and appreciate the contex-
tual nature of evidence informed policy making and the dependence of 
policy debates on issue and policy framing. This would move debates in 
this area beyond the identification of politics as a barrier to evidence use, 
to identify political contestation as a necessary and unavoidable character-
istic of the policy process, which provides the context in which evidence 
use occurs. As we cannot move beyond, or step outside of politics, as some 
would hope, we must develop a more nuanced understanding of how evi-
dence use occurs in the context of political contestation.
For those concerned with the use of evidence to achieve health improve-
ments, this perspective can help to develop strategies which facilitate forms 
of evidence use that serve to identify the most efficient and effective  solutions 
to accepted policy problems. It can also, however, serve as a means of facili-
tating the resolution of protracted policy conflicts. Indeed, a more wide-
spread appreciation of the contested and political nature of policy making, 
and the existence of multiple framings of policy debates, amongst policy 
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actors could potentially lead to more constructive forms of engagement in 
areas of vehement political contestation (such as the current debates about 
e-cigarettes in the UK); rather than seeing opposing sides of debates both 
selecting pieces of evidence on which to claim an ‘evidence based’ position 
(while simultaneously ignoring or dismissing their opponents claims over 
evidence). Understanding that different accounts of policy evidence result 
from different assessments of policy concerns and policy framings, may be 
one way to address the political polarisation over issues and increase the 
chances that competing actors seek effective policy solutions in good faith.
futuRe ReseaRch agenDas
The current volume identifies a number of potential directions for future 
research which build on the insights presented here. While the GRIP- 
health programme, from which this volume emerged, attempted to sam-
ple a range of countries with differing levels of economic development and 
with differing forms of constitutional and institutional arrangements, the 
scope of analysis and comparison between cases was limited by the time 
and data available within an ambitious multi-country study. More focussed 
work should thus be undertaken to explore the different elements of evi-
dence informed policy making that our chapters identify in greater depth, 
with significant scope for further comparative, politically informed studies 
of evidence use in low, middle, and high income settings.
For example, while Chap. 10 draws out lessons from aid-recipient set-
tings, there are many further investigations that could be explored along 
these lines, including to investigate the governance implications of many 
new donor supported efforts to build systems of evidence use in low- 
income settings. Even when not reliant on donor support, we are also 
seeing the development of new domestic administrative arrangements in 
relation to evidence use occurring in many low and middle income set-
tings. These developments could provide a number of cases to explore 
how new arrangements governing evidence use are established and embed-
ded and can provide a number of insights around institutionalisation of 
evidence advisory systems in these settings.
In higher income settings, there is also scope for further comparative 
work to gain insights into how different national political institutions (e.g. 
unitary vs federal systems) may interact with the establishment of evidence 
advisory systems at both national and sub-national levels. Indeed, even 
though two of our country case studies were federal systems (Germany 
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and Ethiopia) the scope of work covered in this volume was unable to 
explore systems of evidence use below national levels to any significant 
degree. There will also be scope to reflect on different types of political 
systems and the degree to which they allow open contestation surround-
ing policy issues and whether or how this affects uses of evidence. Indeed, 
there is a need to go beyond the usual comparisons of countries that are 
seemingly similar in socio-economic terms and to think across low, middle 
and high income settings in a globalised world.
Approaches such as these could add much needed insights into how 
political and institutional factors work to shape the meaning of evidence 
utilisation in different settings, potentially offering lessons for those actors 
interested in improving evidence use according to one or another set of 
normative goals. At present, much public health literature remains focussed 
on the quality of evidence as judged by technical merits of research design, 
with broad calls for uptake of high quality evidence often made without 
consideration of the policy realities involved. As policy actors in the health 
field increasingly recognise that evidence utilisation is governed by systems 
working within political environments, they will need insights from work 
such as this to inform their efforts to improve the governance of evidence 
systems.
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